Adherence & Retention
Fwd: [HEALTHGAP] Webinar: impact of treatment as prevention: models to guide ending the epidemic
---------- Forwarded message ----------
Date: Wed, Jan 25, 2012 at 4:33 PM
Subject: [HEALTHGAP] Webinar: impact of treatment as prevention: models to
guide ending the epidemic
All...
Health GAP, AVAC, and AmFAR will be co-hosting an webinar for civil society
gropus on the impact of expanding ARV treatment on bending the
epidemiological curves for new infections, deaths and illness, and
eventually costs. This is especially important at this moment as PEPFAR
finalizes it's plans for next year and global fund Phase 2 renewals begin
to be reviewed--plus in illustrating could be accomplished with increased
investment in halting the pandemic.
“The Impact of Treatment as Prevention: Models to Guide Ending the
Epidemic” http://mlist.orchidsuites.net/lists/lt.php?id=KkoCAgZVUgBeAB4FCFFRDkoGDlNSCVg%3D
This 60-minute webinar will take place on Thursday, January 26th at 9 AM
EST/4 PM South Africa/5 PM East Africa (see
http://mlist.orchidsuites.net/lists/lt.php?id=KkoCAgZVUgBeAx4FCFFRDkoGDlNSCVg%3D * for the time in your area
*Click here to register.http://mlist.orchidsuites.net/lists/lt.php?id=KkoCAgZVUgBeAB4FCFFRDkoGDlNSCVg%3D>
The webinar will feature a presentation by Dr. John Blandford, chief of the
Division of Global HIV/AIDS Health Economics, Systems, and Integration
Branch at the US Centers for Disease Control and Prevention's Center for
Global Health.
Dr. Blandford will discuss work that he and his team have developed to
project the impact of scaled-up antiretroviral treatment coverage on
health, new infections and financial costs associated with the AIDS
response. Work by Dr. Blandford and others has helped shape global
discussions about the feasibility and potential of using treatment as
prevention—including earlier treatment of HIV at CD4 counts greater than
350—as a key tool for ending the epidemic.
The discussion will be moderated by Chris Collins, Vice President for
Public Policy at amfAR, and Mitchell Warren, Executive Director of AVAC.
Advocates interested in learning about how scaled-up investments in
treatment and other prevention tools today could affect the epidemic over
the long term are encouraged to join this webinar and to email questions in
advance to **.
